Self-monitored photothermal therapy (PTT) with minimal collateral damages has emerged as a challenging strategy for antibacterial and cancer treatments, which could be fulfilled via the rational integration of luminescent thermometry and photothermal ablation within a single upconverting (UC) nanoplatform. Herein, 808 nm light-driven dual-functional nanoplatforms LuVO 4:Nd 3+ /Yb 3+ /Er 3+ @SiO 2 @Cu 2 S were successfully developed using olivelike LuVO 4:Nd 3+ /Yb 3+ /Er 3+ hollow nanoparticles as the thermal-sensing core and ultrasmall Cu 2 S nanoparticles as the photothermal satellite. Irradiated by 808 nm laser, thermal-sensing behaviors of samples were evaluated based on the high-purity Er 3+ green emissions, while the surface-attached Cu 2 S exhibited superior photothermal effects due to the efficient absorption of incident laser and near-infrared emissions from the luminescent core. The feasibility of bifunctional samples acting as self-monitored photothermal agents in subtissues and antibacterial agents against drug-resistant bacteria was separately assessed. Results provide deeper insights into the desirable design of 808 nm-driven multifunctional nanoplatforms with intense UC emission, sensitive thermometry, and effective photothermal conversion toward self-monitored PTT with high therapeutic accuracy.
No takes yet. Share an insight, caveat, or question.
Suo et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: